Ainos CFO says maintained ‘disciplined financial approach’ in FY25

“In 2025 we maintained a disciplined financial approach while supporting SmellTech platform’s scale. Total revenue increased approximately 499% year over year, mainly reflecting progress in our AI Nose commercialization. Gross margin improved significantly to approximately 82.9% in 2025, compared to a gross loss in 2024. Total operating expenses, excluding share-based compensation, depreciation and amortization, decreased 9% year-over-year, reflecting operational discipline as we prepare for deployment-driven growth, while reported operating expense increased about 2%,” Christopher Lee, CFO, commented. “Subsequent to year-end, we strengthened our financial position through a New Taiwan Dollar 90 million financing, providing additional liquidity to support ongoing operations and deployment execution. This capital enhances our flexibility as we scale AI Nose commercialization while maintaining a disciplined approach to capital allocation,” Lee added.